Uppsala Reports Long Reads – Convincing the vaccine hesitant
Listen now
Description
Fuelled by disinformation and an array of other cultural and economic factors, vaccine hesitancy is one of the greatest global health communication challenges of our times. But to craft the empathetic and tailored communication strategies required to boost confidence in vaccines, we first need to understand the difference between anti-vaccination belief and vaccine hesitancy. This episode is part of the Uppsala Reports Long Reads series – the most topical stories from UMC’s pharmacovigilance magazine, brought to you in audio format. Find the original article here. After the read, we speak to Uppsala Reports editor Gerard Ross about the dangers of polarising the conversation on vaccines, the role of social media, and how it all boils down to trust. Tune in to find out: why having questions or worries about vaccines is not the same thing as being anti-vaccinationwhy directing appropriate communication at the vaccine hesitant is more effective than attacking the vaccine deniershow cultural sensitivity and emotional intelligence can benefit pro-vaccine communicationWant to know more? The World Health Organization provides resources on vaccine communication in general and COVID-19 vaccines in particular. The University of Queensland’s online course on Antivaccination and Vaccine Hesitancy is available to people anywhere in the world. For more on vaccine safety and confidence, check out these episodes from the Drug Safety Matters archive: Keeping vaccines safeSubstandard and falsified COVID-19 vaccines in the AmericasVaccination errors risk harm and damage trustFinally, don’t forget to ­subscribe to the monthly Uppsala Reports newsletter for free regular updates from the world of pharmacovigilance. Join the conversation on social media Follow us on Twitter, Facebook or LinkedIn, and share your thoughts about the show with the hashtag #DrugSafetyMatters. Got a story to share? We’re always looking for new content and interesting people to interview. If you have a great idea for a show, get in touch! About UMC Read more about Uppsala Monitoring Centre and how we work to make medicines safer for patients.
More Episodes
Published 02/29/24
Serious and unexpected adverse drug reactions – the ‘black swans’ of pharmacovigilance – can place enormous strain on safety monitoring systems. Drawing examples from the COVID-19 pandemic, François Montastruc from Toulouse University Hospital explains how we can get better at dealing with the...
Published 02/29/24
The liver is the primary site for drug metabolism in the body, but it can be severely damaged by medicines or their toxic compounds. Rita Baião from the North Lisbon University Hospital Center reviews what pharmacovigilance professionals should know about drug-induced liver injury (DILI). Tune...
Published 02/01/24